Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gastrointestinal adsorptive effect describes the mechanism by which certain orally-administered materials (enterosorbents) bind and sequester substances—such as bacterial toxins, bile acids, and sometimes drugs—in the gut, preventing their absorption into the body and promoting their excretion. This effect is non-systemic: the adsorbent agents do not cross the intestinal barrier themselves and are excreted unchanged. The effect is exploited therapeutically in acute poisoning (e.g., activated charcoal), chronic diarrhea, IBS-D, and management of endogenous or exogenous gut-derived toxins. This is not a property of a molecular target such as a receptor, enzyme, or transporter, but rather of the material’s physical-chemical interaction with gut luminal contents. Selection of the adsorbent depends on clinical need (selectivity, safety profile, compatibility with other drugs).
Adsorption and sequestration of target substances (toxins, bile acids, drugs) in the GI lumen, thereby preventing their absorption into systemic circulation and facilitating excretion
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal adsorptive effect.